Aptose Biosciences
APTO1.7100.00% ( 0.000 )
Aptose Biosciences (APTO)
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primar...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 1.710
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- PUBT · Jul 1 at 05:52 AM
Aptose Biosciences deregisters common shares, ends SEC reporting duty
- StockTitan · Jun 30 at 10:32 AM
Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical | APTOF Stock News
- MorningStar · May 14 at 05:20 AM
North American Morning Briefing: AI Trade Top of Mind as Stock Futures Climb -2-
- TradingView · May 13 at 04:23 PM
Aptose Reports Q1 2026 Loss of $7.6M, Cash $4.1M as Acquisition by Hanmi Pending
- Unusual Whales · Apr 26 at 08:41 PM
Aptori Launches Autonomous Offensive Testing to Eliminate the AI-Driven Security Backlog
- Tip Ranks · Mar 31 at 10:33 PM
Aptose Shareholders Approve Hanmi Acquisition and Re-Domiciling
